The decision of some states not to expand Medicaid means that the nation's poorest - those the Affordable Care Act would have helped the most - may not receive any help at all.
The decision of some states not to expand Medicaid means that the nation's poorest — those the Affordable Care Act would have helped the most — may not receive any help at all.
That's because the 2010 law was written to provide Medicaid coverage for those making less than 100% of the federal poverty level, $23,550 for a family of four, in all 50 states. Because those Americans were to get Medicaid coverage, they were not made eligible for the federal tax subsidies that would help them pay for health insurance they will be required to buy.
However, when the Supreme Court ruled last year that the requirement for most uninsured Americans to buy insurance was constitutional, it also ruled that the states did not have to expand Medicaid to continue receiving federal funds for their existing programs.
Read the full story here: http://usat.ly/1fC8Ybz
Source: USA Today
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Upadacitinib Demonstrates Efficacy in RA Treatment Regardless of Patient’s Baseline CRP Levels
November 22nd 2023In a real-world, prospective study, upadacitinib demonstrated great potential for the treatment of rheumatoid arthritis (RA) regardless of a patient’s baseline C-reactive protein (CRP) levels.
Read More
2 Clarke Drive
Cranbury, NJ 08512